Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nausea × Growth Differentiation Factor 15 × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 1 Vomiting 1 Nausea 1 Breast Neoplasms 1

Interventions

Dexamethasone 33 Aprepitant 30 Ondansetron 25 Palonosetron 22 Granisetron 16 Calcium Dobesilate 15 Olanzapine 13 Therapeutics 8 dexamethasone acetate 7 Cyclophosphamide 7 fosaprepitant 6 casopitant 6 Doxorubicin 6 Radiotherapy 5 netupitant 4 dolasetron 4 dexamethasone 21-phosphate 4 Vincristine 4 Tropisetron 4 Metoclopramide 4 Acupressure 4 Prochlorperazine 3 Lorazepam 3 Electroacupuncture 3 Dronabinol 3 Cisplatin 3 peppermint oil 2 netupitant, palosentron drug combination 2 ginger extract 2 auricularum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07465172 2026-03-11

GRADE

Breast Cancer Trials, Australia and New Zealand

Phase NA Not yet recruiting

Breast Neoplasms, Nausea, Vomiting, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡